Please find attached copy of certificates received from Kfin Technologies Limited, Registrar & Share Transfer Agent under Regulation 74(5) of SEBI (Depository & Participants) Regulations, ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Pharma Industries has submitted to BSE the quarterly certificate received from its Registrar & Share Transfer Agent, KFin Technologies Limited, under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018. The certificate, dated October 2, 2025, confirms that KFin has furnished details of securities dematerialised and rematerialised during the quarter ended September 30, 2025 to both NSDL and CDSL as well as to the stock exchanges where the company's shares are listed. The submission was made by Company Secretary Nirav Shah on October 20, 2025. There are no financial figures or transactions disclosed — this is purely a procedural compliance submission with no business substance.
No impact on shareholders or stock price. This is a routine quarterly compliance filing required by SEBI and carries no material information for investors.